Originaltext
Diese Übersetzung bewerten
Mit deinem Feedback können wir Google Übersetzer weiter verbessern
Home
Glenmark Pharmaceuticals Limited
Press Release May 24 2021
Published May 24 2021
5 min read

Press Release May 24 2021

Glenmark Pharmaceuticals Limited has informed the Exchange regarding a press release dated May 24, 2021, titled "Glenmark Pharmaceuticals receives ANDA approval for Icatibant Injection, 30 mg/3 mL (10 mg/mL) Single-Dose Prefilled Syringe".

View Attachment